Bioluminescence Imaging Visualizes Activation of Nuclear Factor-kappaB in Mouse Cardiac Transplantation

Overview

Journal Transplantation

Specialty General Surgery

Date 2008 Mar 25

PMID 18360274

Citations 11

Authors

Lianli Ma

Zhidan Xiang

Taylor P Sherrill

Lei Wang

Timothy S Blackwell

Philip Williams

Anita Chong

Ravi Chari

Deng Ping Yin

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of the current study was to evaluate the role of bioluminescence imaging (BLI) in the determination of nuclear factor (NF)-kappaB activation in cardiac allograft rejection and ischemia-reperfusion injury.

Methods: To visualize NF-kappaB activation, luciferase transgenic mice under the control of a mouse NF-kappaB promoter (NF-kappaB-Luc) were used as donors or recipients of cardiac grafts. Alternatively, NF-kappaB-Luc spleen cells were adoptively transferred into Rag2 -/- mice with or without cardiac allografts. BLI was performed posttransplantation to detect luciferase activity that represents NF-kappaB activation.

Results: The results show that luciferase activity was significantly increased in the cardiac allografts when NF-kappaB-Luc mice were used as recipients as well as donors. Luciferase activity was also elevated in the wild-type cardiac allografts in Rag2 -/- mice that were transferred with NF-kappaB-Luc spleen cells. CD154 monoclonal antibody (mAb) therapy inhibited luciferase activity and induced long-term survival of cardiac allografts. toll-like receptor-9 ligand, CpG DNA, enhanced luciferase activity and abrogated tolerance induction by CD154 mAb. Luciferase activity was also increased in ischemia-reperfusion injury of the cardiac grafts.

Conclusion: BLI using Luc-NF-kappaB mice is a noninvasive approach to visualize the activation of NF-kappaB signaling in mouse cardiac allograft rejection and ischemia-reperfusion injury. CD154 mAb can inhibit NF-kappaB activation, which is reversed by toll-like receptor engagement.

Citing Articles

Gene expression profiling in PBMCs for acute rejection in lung transplant recipients reveals myeloid responses.

Liu S, Westra J, Hu S, Verschuuren E, van Kempen L, van Baarle D Front Transplant. 2025; 3:1508419.

PMID: 39744543 PMC: 11688322. DOI: 10.3389/frtra.2024.1508419.

Gastric Bypass Regulates Early Inflammatory Responses in High-Fat Diet-Induced Obese Mice.

Xu R, Zhu C, Li Y, Andrade M, Yin D J Surg Res. 2022; 273:161-171.

PMID: 35085943 PMC: 8960359. DOI: 10.1016/j.jss.2021.12.027.

Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.

Govender L, Mikulic J, Wyss J, Gaide O, Thome M, Golshayan D Front Immunol. 2020; 11:576651.

PMID: 33042160 PMC: 7517581. DOI: 10.3389/fimmu.2020.576651.

Transgenic Animal Models to Visualize Cancer-Related Cellular Processes by Bioluminescence Imaging.

Manni I, de Latouliere L, Gurtner A, Piaggio G Front Pharmacol. 2019; 10:235.

PMID: 30930779 PMC: 6428995. DOI: 10.3389/fphar.2019.00235.

Molecular Imaging of Acute Cardiac Transplant Rejection: Animal Experiments and Prospects.

Chen Y, Zhang L, Liu J, Zhang P, Chen X, Xie M Transplantation. 2017; 101(9):1977-1986.

PMID: 28538050 PMC: 5568929. DOI: 10.1097/TP.0000000000001780.

References

Phillips N, Markees T, Mordes J, Greiner D, Rossini A . Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance. J Immunol. 2003; 170(6):3015-23. DOI: 10.4049/jimmunol.170.6.3015. View

Frantz S, Tillmanns J, Kuhlencordt P, Schmidt I, Adamek A, Dienesch C . Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. Am J Pathol. 2007; 171(2):507-12. PMC: 1934536. DOI: 10.2353/ajpath.2007.061042. View

Ueki S, Yamashita K, Aoyagi T, Haga S, Suzuki T, Itoh T . Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Transplantation. 2007; 82(12):1720-7. DOI: 10.1097/01.tp.0000250548.13063.44. View

Smiley S, Csizmadia V, Gao W, Turka L, Hancock W . Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation. 2000; 70(3):415-9. DOI: 10.1097/00007890-200008150-00005. View

Zhou P, Hwang K, Palucki D, Guo Z, Boothby M, Newell K . Impaired NF-kappaB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts. Am J Transplant. 2003; 3(2):139-47. DOI: 10.1034/j.1600-6143.2003.00033.x. View

Thornley T, Brehm M, Markees T, Shultz L, Mordes J, Welsh R . TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol. 2006; 176(3):1561-70. PMC: 3916149. DOI: 10.4049/jimmunol.176.3.1561. View

Yull F, Han W, Jansen E, Everhart M, Sadikot R, Christman J . Bioluminescent detection of endotoxin effects on HIV-1 LTR-driven transcription in vivo. J Histochem Cytochem. 2003; 51(6):741-9. DOI: 10.1177/002215540305100605. View

Lentsch A . Activation and function of hepatocyte NF-kappaB in postischemic liver injury. Hepatology. 2005; 42(1):216-8. DOI: 10.1002/hep.20779. View

Lee J, Burckart G . Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol. 1998; 38(11):981-93. DOI: 10.1177/009127009803801101. View

10.

Larsen C, Alexander D, Hollenbaugh D, Elwood E, Ritchie S, Aruffo A . CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation. 1996; 61(1):4-9. DOI: 10.1097/00007890-199601150-00002. View

11.

Blackwell J, Searle S . Genetic regulation of macrophage activation: understanding the function of Nramp1 (=Ity/Lsh/Bcg). Immunol Lett. 1999; 65(1-2):73-80. DOI: 10.1016/s0165-2478(98)00127-8. View

12.

Andrade C, Kaneda H, Der S, Tsang M, Lodyga M, Dos Santos C . Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation. J Heart Lung Transplant. 2006; 25(11):1317-23. DOI: 10.1016/j.healun.2006.09.017. View

13.

Sadikot R, Blackwell T . Bioluminescence imaging. Proc Am Thorac Soc. 2005; 2(6):537-40, 511-2. PMC: 2713342. DOI: 10.1513/pats.200507-067DS. View

14.

Krieger N, Yin D, Fathman C . CD4+ but not CD8+ cells are essential for allorejection. J Exp Med. 1996; 184(5):2013-8. PMC: 2192869. DOI: 10.1084/jem.184.5.2013. View

15.

Shen J, Chong A, Xiao F, Liu W, Huang W, Blinder L . Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Transplantation. 1998; 66(6):692-8. DOI: 10.1097/00007890-199809270-00002. View

16.

Kaibori M, Sakitani K, Oda M, Kamiyama Y, Masu Y, Nishizawa M . Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. J Hepatol. 1999; 30(6):1138-45. DOI: 10.1016/s0168-8278(99)80270-0. View

17.

Shen X, Ke B, Zhai Y, Gao F, Busuttil R, Cheng G . Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant. 2005; 5(8):1793-800. DOI: 10.1111/j.1600-6143.2005.00932.x. View

18.

Chen X, Zhang X, Larson C, Baker M, Kaufman D . In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation. 2006; 81(10):1421-7. DOI: 10.1097/01.tp.0000206109.71181.bf. View

19.

Boyd J, Mathur S, Wang Y, Bateman R, Walley K . Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res. 2006; 72(3):384-93. DOI: 10.1016/j.cardiores.2006.09.011. View

20.

Takahashi Y, Ganster R, Gambotto A, Shao L, Kaizu T, Wu T . Role of NF-kappaB on liver cold ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2002; 283(5):G1175-84. DOI: 10.1152/ajpgi.00515.2001. View